Items Tagged ‘mpn’

December 6, 2017

Fedratinib May Represent New Option for Jakafi-Resistant Myelofibrosis


Patients with myelofibrosis resistant or intolerant to Jakafi (ruxolitinib) may have an alternative treatment option with a novel JAK2-selective inhibitor fedratinib, according to the results of clinical study recently published in the medical journal Lancet.1 About Myelofibrosis Myelofibrosis is a type of blood cancer known as a myeloproliferative neoplasm that is chronic and progressive in […]

View full entry

Tags: essential thrombocytosis, fedratinib, jakafi, mpn, myelofibrosis, myeloproliferative neoplasm, Myeloproliferative Neoplasms MPN, News, polycythemia vera, ruxolitinib